CD4+CD25+ T Regulatory Cells, Immunotherapy of Cancer, and Interleukin-2
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Cancer Research,Pharmacology,Immunology,Immunology and Allergy
Reference98 articles.
1. Selective in vitro growth of T lymphocytes from normal human bone marrows.;Morgan;Science,1976
2. Human immune disorder arising from mutation of the alpha chain of the interleukin-2 receptor.;Sharfe;Proc Natl Acad Sci USA,1997
3. Homeostasis of peripheral CD4+ T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4+ T cell numbers.;Almeida;J Immunol,2002
4. CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity.;Belkaid;Nature,2002
5. CD4(+)CD25(+) T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells.;Suri-Payer;J Immunol,1998
Cited by 180 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Non‐IL‐2‐blocking anti‐CD25 antibody inhibits tumor growth by depleting Tregs and has synergistic effects with anti‐CTLA‐4 therapy;International Journal of Cancer;2024-01-05
2. Has the shortage of fludarabine altered the current paradigm of lymphodepletion in favor of bendamustine?;Frontiers in Immunology;2023-11-22
3. Efficient T cell adoptive transfer in lymphoreplete hosts mediated by transient activation of Stat5 signaling;Molecular Therapy;2023-09
4. ARTISTRY-7: phase III trial of nemvaleukin alfa plus pembrolizumab vs chemotherapy for platinum-resistant ovarian cancer;Future Oncology;2023-07
5. NL-201 Upregulates MHC-I Expression and Intratumoral T-cell Receptor Diversity, and Demonstrates Robust Antitumor Activity as Monotherapy and in Combination with PD-1 Blockade;Cancer Immunology Research;2023-05-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3